Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is expected to see strong organic growth and valuation improvements with their increased focus on senior housing properties, as seen through their target to have 100% of their portfolio in this segment in the long-term. With experienced leadership and strategic decisions to sell MOB assets and invest in high-yielding SHOP assets, the company has the potential for above-average growth in the future. Additionally, NHP's recent IPO and use of funds to reduce leverage further highlights their commitment to strengthening their overall financial position.

Bears say

National Healthcare is facing headwinds in its transition to a portfolio more focused on senior housing operating properties, and a lack of operating history and need to dispose of inefficient outpatient medical facilities have led to a discount in its share price. The company's geographic concentration in the Southeast, Midwest, and Northeast regions leave it vulnerable to potential economic headwinds and adverse regulatory conditions. Furthermore, high management turnover and potential challenges in retaining key personnel could negatively impact the company's operations, cash flow, and valuation.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Jun 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.